8-K: Planet 13 Sells Florida Medical Marijuana License for $9 Million to Facilitate VidaCann Acquisition

Planet 13 Holdings Inc. has entered into an agreement to sell its Florida medical marijuana treatment center license for $9 million in cash, a key step in its acquisition of VidaCann, LLC.

Summary

• Planet 13 Holdings Inc. has agreed to sell its Florida medical marijuana treatment center license to SGW FL Enterprises, LLC for $9 million in cash.
• This sale is a necessary condition for Planet 13 to proceed with its previously announced acquisition of VidaCann, LLC.
• The transaction is expected to close in the first quarter of 2024, pending regulatory approvals and the closing of the VidaCann acquisition.
• The $9 million cash infusion from the sale will help Planet 13 finance the VidaCann acquisition and integration.
• The agreement includes customary representations, warranties, and covenants, with both parties agreeing to use commercially reasonable efforts to complete the transaction.
• The agreement can be terminated if the transaction is not completed by May 31, 2024.

Sentiment

Score: 7

Explanation: The sentiment is positive as the sale is a necessary step for a larger strategic acquisition, and the company is receiving a significant cash infusion. However, there are risks associated with regulatory approvals and the closing of the VidaCann acquisition.

Positives

• The sale of the Florida license provides Planet 13 with $9 million in cash.
• The sale allows Planet 13 to move forward with the acquisition of VidaCann.
• The transaction is expected to close relatively quickly, in the first quarter of 2024.
• The all-cash return from the sale will help facilitate closing and integrating VidaCann.

Negatives

• The sale of the Florida license means Planet 13 will no longer directly operate in the Florida market.
• The transaction is subject to regulatory approvals, which could potentially delay or prevent the closing.
• The deal is contingent on the simultaneous closing of the VidaCann acquisition, adding another layer of complexity.

Risks

• The transaction is subject to regulatory approvals, which may be delayed or not received.
• The accuracy of the parties' representations and warranties is a condition of closing.
• The performance of the parties' obligations under the agreement is a condition of closing.
• The simultaneous closing of the VidaCann acquisition is a condition of closing.
• The agreement can be terminated if the transaction is not completed by May 31, 2024.
• There is a risk that the sale could negatively impact Planet 13's business or stock price.

Future Outlook

The company expects the transaction to close in the first quarter of 2024, subject to customary closing conditions, including regulatory approvals and the simultaneous closing of the VidaCann acquisition. The company plans to use the proceeds to facilitate the VidaCann acquisition and integration.

Management Comments

• Bob Groesbeck, Co-CEO of Planet 13, stated that the sale of the surplus license was the primary step required to move forward with the acquisition of VidaCann.
• He also mentioned that the cash return from the sale will help facilitate closing and integrating VidaCann.

Industry Context

This announcement reflects the ongoing consolidation and strategic maneuvering within the cannabis industry, where companies are focusing on key markets and assets. Planet 13 is divesting a non-core asset to fund a more strategic acquisition, which is a common practice in the industry.

Comparison to Industry Standards

• The sale of a single state license for $9 million is within the range of similar transactions in the cannabis industry, although the value of licenses can vary significantly based on market size, regulatory environment, and the specific terms of the license.
• Other multi-state operators (MSOs) such as Curaleaf, Trulieve, and Green Thumb Industries have also engaged in similar asset sales and acquisitions to optimize their portfolios and expand their reach.
• The focus on vertical integration and strategic acquisitions, as seen in Planet 13's move to acquire VidaCann, is a common trend among larger cannabis companies seeking to control their supply chain and expand their retail footprint.

Stakeholder Impact

• Shareholders will likely view the sale positively as it facilitates the VidaCann acquisition.
• Employees of Planet 13 Florida will be impacted by the sale, as the company will no longer operate in Florida.
• Customers in Florida will be impacted as the license will be transferred to a new operator.
• Suppliers and creditors of Planet 13 Florida will be impacted by the sale.

Next Steps

• Planet 13 needs to obtain regulatory approvals for the sale of the Florida license.
• Planet 13 needs to complete the acquisition of VidaCann.
• SGW FL Enterprises, LLC needs to obtain regulatory approvals for the transfer of the Florida license.
• Both parties need to fulfill their obligations under the Stock Purchase Agreement.

Key Dates

Keywords

Planet 13, VidaCann, medical marijuana, cannabis, Florida, acquisition, license, sale, MMTC, regulatory approvals